Login / Signup

In vitro and in vivo evidence discourages routine testing and reporting of piperacillin/tazobactam susceptibility of Elizabethkingia species.

Mei-Chen TanYing-Chi HuangPei-Jing ChenWei-Cheng HuangShu-Yuan HsuHui-Ying WangCi-Hong LiouJun-Ren SunTsai-Ling Yang LauderdaleShu-Chen Kuo
Published in: The Journal of antimicrobial chemotherapy (2023)
Keyphrases
  • clinical practice
  • adverse drug
  • gram negative
  • emergency department
  • genetic diversity